Brand Name
Sensipar
Generic Name
Cinacalcet
View Brand Information FDA approval date: April 04, 2004
Classification: Calcium-sensing Receptor Agonist
Form: Tablet
What is Sensipar (Cinacalcet)?
Sensipar is a positive modulator of the calcium sensing receptor indicated for: Secondary Hyperparathyroidism in adult patients with chronic kidney disease on dialysis.
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment
Related Latest Advances
There is no latest advances for this treatment